Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Women's Implant Information Network

This article was originally published in The Gray Sheet

Executive Summary

Writes FDA to object to an Aug. 4 Public Citizen Health Research Group's citizen's petition on the premarket approval of saline-filled breast implants. The HRG petition asked FDA to immediately call for premarket approval applications for the devices and to restrict use of the devices to controlled clinical trials until more safety data is gathered ("The Gray Sheet" Aug. 8, p. 7). WIIN criticizes the HRG petition's "blatant omission of recent peer-reviewed epidemiological studies that indicate no causal relationship between breast implants and disease" and says that "many" articles cited in the petition "are as much as 20 years old." The group asserts that "in the absence of adverse scientific studies, implants should be available to women regardless of motivation"

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002809

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel